HKD 0.02
(-5.26%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | -19.68 Million HKD | -82.43% |
2022 | -4.56 Million CNY | -111.5% |
2021 | 35.48 Million CNY | 23.92% |
2020 | -7.36 Million CNY | 192.92% |
2019 | -60.29 Million CNY | 81.26% |
2018 | -183.97 Million CNY | -6.95% |
2017 | -172.01 Million CNY | -131.45% |
2016 | -74.31 Million CNY | -283.22% |
2015 | -19.39 Million CNY | -108.52% |
2014 | 227.56 Million CNY | -28.55% |
2013 | 318.51 Million CNY | 2.36% |
2012 | 386.43 Million CNY | 34.95% |
2011 | 284.35 Million CNY | 33.89% |
2010 | 202.06 Million CNY | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q2 | -13.06 Million HKD | 0.0% |
2023 FY | - HKD | -82.43% |
2023 Q4 | -6.28 Million HKD | 0.0% |
2023 Q2 | -15.03 Million HKD | 0.0% |
2022 Q2 | -58.23 Million HKD | 0.0% |
2022 FY | - CNY | -111.5% |
2021 FY | - CNY | 23.92% |
2020 FY | - CNY | 192.92% |
2019 FY | - CNY | 81.26% |
2018 FY | - CNY | -6.95% |
2017 FY | - CNY | -131.45% |
2016 FY | - CNY | -283.22% |
2015 FY | - CNY | -108.52% |
2014 FY | - CNY | -28.55% |
2013 FY | - CNY | 2.36% |
2013 Q4 | 58.12 Million CNY | -28.32% |
2013 Q3 | 81.08 Million CNY | 0.0% |
2013 Q2 | 81.08 Million CNY | 0.0% |
2013 Q1 | 81.08 Million CNY | 0.0% |
2012 Q4 | 81.08 Million CNY | 4.24% |
2012 Q1 | 77.78 Million CNY | 0.0% |
2012 FY | - CNY | 34.95% |
2012 Q2 | 77.78 Million CNY | 0.0% |
2012 Q3 | 77.78 Million CNY | 0.0% |
2011 Q2 | 57.64 Million CNY | 0.0% |
2011 FY | - CNY | 33.89% |
2011 Q4 | 77.78 Million CNY | 34.95% |
2011 Q3 | 57.64 Million CNY | 0.0% |
2011 Q1 | 57.64 Million CNY | 0.0% |
2010 FY | - CNY | 0.0% |
2010 Q4 | 57.64 Million CNY | 33.89% |
2010 Q3 | 43.05 Million CNY | 0.0% |
2010 Q2 | 43.05 Million CNY | 0.0% |
2010 Q1 | 43.05 Million CNY | 0.0% |
2009 Q4 | 43.05 Million CNY | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Natural Beauty Bio-Technology Limited | 22.91 Million HKD | 185.92% |
Innovative Pharmaceutical Biotech Limited | 317.74 Million HKD | 106.196% |
China Overseas Nuoxin International Holdings Limited | 2.02 Million HKD | 1070.232% |
Huasheng International Holding Limited | 19.67 Million HKD | 200.041% |
Fourace Industries Group Holdings Limited | 61.52 Million HKD | 131.997% |
Evergreen Products Group Limited | 140.78 Million HKD | 113.983% |
EC Healthcare | 737.83 Million HKD | 102.668% |
Ming Fai International Holdings Limited | 211.83 Million HKD | 109.293% |
Blue Moon Group Holdings Limited | 656.37 Million HKD | 102.999% |
SuperRobotics Holdings Limited | -7.39 Million HKD | -166.063% |
Takbo Group Holdings Limited | 25.8 Million HKD | 176.29% |
Hyfusin Group Holdings Limited | 154.18 Million HKD | 112.768% |